These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36821759)

  • 21. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass.
    DeAnda A; Coutre SE; Moon MR; Vial CM; Griffin LC; Law VS; Komeda M; Leung LL; Miller DC
    Ann Thorac Surg; 1994 Aug; 58(2):344-50. PubMed ID: 8067830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulation for cardiac surgery in patients receiving preoperative heparin: use of the high-dose thrombin time.
    Shore-Lesserson L; Manspeizer HE; Bolastig M; Harrington D; Vela-Cantos F; DePerio M
    Anesth Analg; 2000 Apr; 90(4):813-8. PubMed ID: 10735781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of combined anticoagulation using heparin and bivalirudin on the hemostatic and inflammatory responses to cardiopulmonary bypass in the rat.
    Welsby IJ; Jones WL; Arepally G; De Lange F; Yoshitani K; Phillips-Bute B; Grocott HP; Becker R; Mackensen GB
    Anesthesiology; 2007 Feb; 106(2):295-301. PubMed ID: 17264724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of factor IXa by the pegnivacogin system during cardiopulmonary bypass: a potential substitute for heparin. A study in baboons.
    Bel A; Borik W; Davidson S; Helies JM; Stimmer L; Fremes S; Zelenkofske S; Rusconi C; Alexander J; Alexander D; Menasché P; Pepper J
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):682-9. PubMed ID: 25953802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of a thrombin inhibitor peptide as an alternative to heparin in cardiopulmonary bypass surgery.
    Chomiak PN; Walenga JM; Koza MJ; Reilly TM; Turlapathy P; Pifarre R
    Circulation; 1993 Nov; 88(5 Pt 2):II407-12. PubMed ID: 7993389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device Placement.
    Faella KH; Whiting D; Fynn-Thompson F; Matte GS
    J Extra Corpor Technol; 2016 Mar; 48(1):39-42. PubMed ID: 27134308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass.
    Zulys VJ; Teasdale SJ; Michel ER; Skala RA; Keating SE; Viger JR; Glynn MF
    Anesthesiology; 1989 Dec; 71(6):870-7. PubMed ID: 2589675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series.
    Nuttall GA; Oliver WC; Santrach PJ; McBane RD; Erpelding DB; Marver CL; Zehr KJ
    Anesth Analg; 2003 Feb; 96(2):344-50, table of contents. PubMed ID: 12538175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintenance of blood heparin concentration rather than activated clotting time better preserves the coagulation system in hypothermic cardiopulmonary bypass.
    Shirota K; Watanabe T; Takagi Y; Ohara Y; Usui A; Yasuura K
    Artif Organs; 2000 Jan; 24(1):49-56. PubMed ID: 10677157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased anticoagulation during cardiopulmonary bypass by prostaglandin E1.
    Kozek-Langenecker SA; Wanzel O; Berger R; Kettner SC; Coraim F
    Anesth Analg; 1998 Nov; 87(5):985-8. PubMed ID: 9806669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patients.
    Koster A; Hansen R; Kuppe H; Hetzer R; Crystal GJ; Mertzlufft F
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):243-8. PubMed ID: 10890473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot study.
    Riess FC; Poetzsch B; Madlener K; Cramer E; Doll KN; Doll S; Lorke DE; Kormann J; Mueller-Berghaus G
    Thorac Cardiovasc Surg; 2007 Jun; 55(4):233-8. PubMed ID: 17546553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiopulmonary bypass in humans: bypassing unfractionated heparin.
    Frederiksen JW
    Ann Thorac Surg; 2000 Oct; 70(4):1434-43. PubMed ID: 11081925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normothermic cardiopulmonary bypass increases heparin requirements necessary to maintain anticoagulation.
    Ereth MH; Fisher BR; Cook DJ; Nuttall GA; Orszulak TA; Oliver WC
    J Clin Monit Comput; 1998 Jul; 14(5):323-7. PubMed ID: 9951757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjusted calculation model of heparin management during cardiopulmonary bypass in obese patients: A randomised controlled trial.
    Vienne M; Haas E; Wipf T; Grunebaum L; Levy F; Sattler L; Hoang Minh T; Severac F; Tacquard C; Collange O; Mertes PM; Steib A
    Eur J Anaesthesiol; 2018 Aug; 35(8):613-620. PubMed ID: 29521662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bivalirudin: alternative anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
    Grubb KJ; Salehi P; Chedrawy EG
    Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):20-4. PubMed ID: 19903167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.